Answer
Close monitoring is recommended during Emblaveo treatment in patients with hepatic impairment because elevated liver enzymes have been observed with Emblaveo.
Sources for this answer
- Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked